Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.65% | 40.35 | 0.9% | $2406.88m | |
| JNJ | Johnson & Johnson | 0.83% | 150.24 | 0.7% | $1152.56m | |
| ABBV | AbbVie, Inc. | 2.42% | 107.27 | 1.9% | $937.70m | |
| MRK | Merck & Co., Inc. | 0.57% | 81.91 | 0.7% | $681.87m | |
| BMY | Bristol-Myers Squibb Co. | 0.85% | 62.31 | 1.0% | $627.96m | |
| LLY | Eli Lilly & Co. | 3.05% | 148.50 | 1.1% | $611.14m | |
| AZN | AstraZeneca Plc | 1.82% | 53.74 | 1.2% | $375.21m | |
| TTNP | Titan Pharmaceuticals, Inc. | -3.85% | 3.50 | 17.1% | $266.44m | |
| GSK | GlaxoSmithKline Plc | 0.62% | 37.50 | 0.2% | $214.98m | |
| NVS | Novartis AG | 1.52% | 91.61 | 0.2% | $191.99m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | 12.79% | 112.01 | 0.0% | $146.59m | |
| RGEN | Repligen Corp. | 0.60% | 188.33 | 7.1% | $92.93m | |
| SBTX | Silverback Therapeutics, Inc. | 19.05% | 25.00 | 0.0% | $88.29m | |
| KNTE | Kinnate Biopharma, Inc. | 11.35% | 43.46 | 0.0% | $86.26m | |
| NVO | Novo Nordisk A/S | 0.89% | 67.81 | 0.1% | $83.43m |
Company Profile
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY.